BioCareSD, a BioCare company and national specialty pharmaceutical distributor, today announced a new partnership with WeInfuse, a leading infusion management technology platform used by providers across more than 1,300 locations nationwide. The collaboration will enable closer...
A leading innovator and next-generation specialty group purchasing organization (GPO), and BioCareSD®, a national specialty drug distributor with nearly 50 years of experience delivering life‑saving therapies through high‑touch service and a differentiated distribution model, today announced...
LogiCare3PL today announced it has been selected by Harrow, Inc. (Nasdaq: HROW) as a distribution partner for Harrow's portfolio of ophthalmic disease management solutions. Effective February 1, 2026, LogiCare3PL is providing both non-title and 3PL title...
– By Jennifer Waters, SVP, Retina. Why Retina Practices Need Clear Line of Sight Into Every Dollar of “Savings” In today’s retina distribution landscape, pricing can look clean and simple on the surface—one neat “net price,” often positioned...
– By Jennifer Waters, SVP, Retina. Why Retina Practices Must Demand Transparency, Flexibility, and True Value from Their Distributors The Illusion of a “Good Deal” Specialty distribution in retina care is riddled with complex pricing models and vague value...
LogiCare3PL, a division of BioCare, Inc., is pleased to announce a strategic partnership with ChiRhoClin, Inc., a leader in pancreatic and gastrointestinal diagnostics. Effective July 14, 2025, LogiCare3PL will serve as the exclusive third-party logistics provider...
Oklahoma Cancer Specialists and Research Institute (OCSRI), a leading independent community oncology practice, has officially selected BioCareSD and AllyGPO as its primary specialty drug distributor and group purchasing organization (GPO). This strategic partnership marks a milestone for both organizations and underscores...
LogiCare3PL is proud to support the commercial launch of VYKAT™ XR, Soleno Therapeutics' newly FDA-approved therapy and the first and only treatment indicated for hyperphagia in patients with Prader-Willi syndrome (PWS). This milestone marks a significant advancement...
Ensuring that life-saving medications reach the right patients efficiently, securely, and in compliance with stringent regulations is a top priority. For manufacturers of rare disease therapies and specialty drugs, exclusive distribution partnerships with a third-party logistics...
Switching healthcare Third-Party Logistics (3PL) providers is a serious undertaking—especially in the biopharma industry, where precision and compliance are critical. If your company is planning a 3PL transition in 2025, careful planning and execution are key...
